[Tuberculosis sequelae: clinical aspects]

S Harada1, Y Harada, Y Kitahara

  • 1Ohmuta National Hospital, Fukuoka, Japan.

Kekkaku : [Tuberculosis]
|December 1, 1990
PubMed

Insights

Tuberculosis sequelae, or lung deformities after tuberculosis healing, affect about 6% of pulmonary disease patients. These conditions, including infections and chronic failure, are linked to local chest defects and have a significant mortality rate.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Medical Consequences of Tuberculosis

Context:

  • Tuberculosis sequelae represent long-term pulmonary complications following tuberculosis (TB) treatment.
  • Understanding these sequelae is crucial for managing chronic respiratory conditions and improving patient outcomes.

Purpose:

  • To investigate the characteristics, clinical manifestations, and outcomes of tuberculosis sequelae.
  • To identify risk factors and patterns associated with the development of these post-tuberculosis lung deformities.

Summary:

  • Tuberculosis sequelae were identified in approximately 6% of pulmonary disease patients, encompassing repeated lower respiratory tract infections, pulmonary aspergilloma, atypical mycobacteriosis, and chronic respiratory failure.
  • Patients with sequelae were younger, with a 2:1 male-to-female ratio. Pulmonary aspergilloma patients were younger than those with atypical mycobacteriosis. Mortality rates were significant, particularly for atypical mycobacteriosis and chronic respiratory failure.
  • Chest X-rays revealed common findings like fibrosis, emphysema, bronchial deformities, and residual cavities. Systemic complications were comparable to controls, though specific immune markers were elevated in certain sequelae groups. Local chest defects appear to be a primary factor.

Impact:

  • This study highlights the significant burden of tuberculosis sequelae, emphasizing the need for targeted monitoring and management strategies.
  • Findings suggest that local thoracic structural defects play a key role in the pathogenesis of tuberculosis sequelae, informing future research and clinical practice.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...